Evidence map›Paper›PMID 27688762›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Noninvasive chromosome screening of human embryos by genome sequencing of embryo culture medium for in vitro fertilization.

Juanjuan Xu, Rui Fang, Li Chen, Daozhen Chen, Jian-Ping Xiao, Weimin Yang, Honghua Wang, Xiaoqing Song, Ting Ma, Shiping Bo and 7 more

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 106 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 2 pooled it
58.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04711239 withdrawnnot on this mapstarted 2021, after this paper: background citation

Non-invasive Preimplantation Genetic Testing for Aneuploidies (niPGT-A) - Evaluation of the Analysis of Cell-free DNA in Spent Culture Medium

TypeobservationalSponsorART Fertility Clinics LLCRan2021 to 2021Enrolled0ConditionsSecondary InfertilityArmsPGT-A / niPGT-A
NCT04856696 nacompletednot on this mapstarted 2021, after this paper: background citation

Clinical Application of Non-invasive Preimplantation Genetic Testing for Aneuploidies

TypeinterventionalSponsorKaohsiung Veterans General Hospital.Ran2021 to 2023Enrolled22ConditionsGenetic TestingArmsPGT-A, non-invasive PGT-A
NCT05685147 naunknown statusnot on this mapstarted 2023, after this paper: background citation

A Randomized Double Blind Controlled Trial of Non-invasive Preimplantation Genetic Testing for Aneuploidy in Women With Recurrent Pregnancy Loss

TypeinterventionalSponsorQueen Mary Hospital, Hong KongRan2023 to 2026Enrolled152ConditionsInfertilityArmsNon-invasive Preimplantation genetic testing for aneuploidy status
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 2 syntheses or guidelines pooled it, 279 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Noninvasive Biomarkers of Human Embryo Developmental Potential.International journal of molecular sciences · 2025
    Review
  18. Review
  19. Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 4 countries.

Juanjuan XuReproductive Medical Center of Nanjing Jinling Hospital and the Collaborative Innovation Platform for Reproductive Biology and Technology, Nanjing University School of Medicine, Nanjing, Jiangsu 210002, China.
Rui FangReproductive Medicine Center, Wuxi Maternity and Child Health Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China.
Li ChenReproductive Medical Center of Nanjing Jinling Hospital and the Collaborative Innovation Platform for Reproductive Biology and Technology, Nanjing University School of Medicine, Nanjing, Jiangsu 210002, China.
Daozhen ChenReproductive Medicine Center, Wuxi Maternity and Child Health Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China.
Jian-Ping XiaoReproductive Medicine Center, Wuxi Maternity and Child Health Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China.
Weimin YangReproductive Medicine Center, Wuxi Maternity and Child Health Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China.
Honghua WangReproductive Medicine Center, Wuxi Maternity and Child Health Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China.
Xiaoqing SongReproductive Medicine Center, Wuxi Maternity and Child Health Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China.
Ting MaDepartment of Clinical Research, Yikon Genomics Company, Ltd., Shanghai 201499, China.
Shiping BoDepartment of Clinical Research, Yikon Genomics Company, Ltd., Shanghai 201499, China.
Chong ShiDepartment of Clinical Research, Yikon Genomics Company, Ltd., Shanghai 201499, China.
Jun RenDepartment of Clinical Research, Yikon Genomics Company, Ltd., Shanghai 201499, China.
Lei HuangBiodynamic Optical Imaging Center (BIOPIC), School of Life Sciences, Peking University, Beijing 100871, China; Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Boston, MA 02115; Harvard Medical School, Boston, MA 02115; Beijing Advanced Innovation Center for Genomics, Peking University, Beijing 100871, China.
Li-Yi CaiReproductive Medicine Center, Wuxi Maternity and Child Health Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214002, China; caili76@hotmail.co.jp yaobing@nju.edu.cn xie@chemistry.harvard.edu lusijia@yikongenomics.com.
Bing YaoReproductive Medical Center of Nanjing Jinling Hospital and the Collaborative Innovation Platform for Reproductive Biology and Technology, Nanjing University School of Medicine, Nanjing, Jiangsu 210002, China; caili76@hotmail.co.jp yaobing@nju.edu.cn xie@chemistry.harvard.edu lusijia@yikongenomics.com.
X Sunney XieBiodynamic Optical Imaging Center (BIOPIC), School of Life Sciences, Peking University, Beijing 100871, China; Beijing Advanced Innovation Center for Genomics, Peking University, Beijing 100871, China; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 01238 caili76@hotmail.co.jp yaobing@nju.edu.cn xie@chemistry.harvard.edu lusijia@yikongenomics.com.
Sijia LuDepartment of Clinical Research, Yikon Genomics Company, Ltd., Shanghai 201499, China; caili76@hotmail.co.jp yaobing@nju.edu.cn xie@chemistry.harvard.edu lusijia@yikongenomics.com.
Nanjing Medical University · CNSinotech Genomics (China) · CNNanjing General Hospital of Nanjing Military Command · CNNanjing Maternity and Child Health Care Hospital · CNHarvard University · USPeking University · CNSydney Local Health District · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preimplantation genetic screening (PGS) is widely used to select in vitro-fertilized embryos free of chromosomal abnormalities and to improve the clinical outcome of in vitro fertilization (IVF). A disadvantage of PGS is that it requires biopsy of the preimplantation human embryo, which can limit the clinical applicability of PGS due to the invasiveness and complexity of the process. Here, we present and validate a noninvasive chromosome screening (NICS) method based on sequencing the genomic DNA secreted into the culture medium from the human blastocyst. By using multiple annealing and looping-based amplification cycles (MALBAC) for whole-genome amplification (WGA), we performed next-generation sequencing (NGS) on the spent culture medium used to culture human blastocysts (n = 42) and obtained the ploidy information of all 24 chromosomes. We validated these results by comparing each with their corresponding whole donated embryo and obtained a high correlation for identification of chromosomal abnormalities (sensitivity, 0.882, and specificity, 0.840). With this validated NICS method, we performed chromosome screening on IVF embryos from seven couples with balanced translocation, azoospermia, or recurrent pregnancy loss. Six of them achieved successful clinical pregnancies, and five have already achieved healthy live births thus far. The NICS method avoids the need for embryo biopsy and therefore substantially increases the safety of its use. The method has the potential of much wider chromosome screening applicability in clinical IVF, due to its high accuracy and noninvasiveness.

Indexed as

Chromosome MappingEmbryo, MammalianFertilization in VitroGenome, HumanGenomicsWhole Genome SequencingAdultBlastocystCulture Media, ConditionedEmbryo Culture TechniquesFemaleHigh-Throughput Nucleotide SequencingHumansMalePregnancyPregnancy OutcomeCulture Media, Conditionedchromosomal abnormalitiesIVFMALBACPGSWGA

Identifiers

PMID27688762
PMCPMC5081593
OpenAlexW2524720610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.